Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 18:13:837500.
doi: 10.3389/fphar.2022.837500. eCollection 2022.

The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease

Affiliations
Review

The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease

Yinghui Huang et al. Front Pharmacol. .

Abstract

Emerging evidences demonstrate the involvement of gut microbiota in the progression of chronic kidney disease (CKD) and CKD-associated complications including cardiovascular disease (CVD) and intestinal dysfunction. In this review, we discuss the interactions between the gut, kidney and heart in CKD state, and elucidate the significant role of intestinal microbiota in the gut-kidney-heart axis hypothesis for the pathophysiological mechanisms of these diseases, during which process mitochondria may serve as a potential therapeutic target. Dysregulation of this axis will lead to a vicious circle, contributing to CKD progression. Recent studies suggest novel therapies targeting gut microbiota in the gut-kidney-heart axis, including dietary intervention, probiotics, prebiotics, genetically engineered bacteria, fecal microbiota transplantation, bacterial metabolites modulation, antibiotics, conventional drugs and traditional Chinese medicine. Further, the identification of specific microbial communities and their corresponding pathophysiological metabolites and the illumination of the gut-kidney-heart axis may contribute to innovative basic research, clinical trials and therapeutic strategies against CKD progression and uremic complications in CKD patients.

Keywords: cardiovascular disease; chronic kidney disease; gut microbiota; gut-kidney-heart axis; intestinal dysfunction.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
The gut-kidney-heart axis hypothesis.
FIGURE 2
FIGURE 2
Uremic toxins in the gut-kidney-heart axis.

References

    1. Ahrens A. P., Culpepper T., Saldivar B., Anton S., Stoll S., Handberg E. M., et al. (2021). A Six-Day, Lifestyle-Based Immersion Program Mitigates Cardiovascular Risk Factors and Induces Shifts in Gut Microbiota, Specifically Lachnospiraceae, Ruminococcaceae, Faecalibacterium prausnitzii: A Pilot Study. Nutrients 13 (10), 3459. 10.3390/nu13103459 - DOI - PMC - PubMed
    1. Akizawa T., Asano Y., Morita S., Wakita T., Onishi Y., Fukuhara S., et al. (2009). Effect of a Carbonaceous Oral Adsorbent on the Progression of CKD: A Multicenter, Randomized, Controlled Trial. Am. J. Kidney Dis. 54 (3), 459–467. 10.1053/j.ajkd.2009.05.011 - DOI - PubMed
    1. Alamir I., Niquet-Leridon C., Jacolot P., Rodriguez C., Orosco M., Anton P. M., et al. (2013). Digestibility of Extruded Proteins and Metabolic Transit of N ε -carboxymethyllysine in Rats. Amino Acids 44 (6), 1441–1449. 10.1007/s00726-012-1427-3 - DOI - PubMed
    1. Aragno M., Mastrocola R. (2017). Dietary Sugars and Endogenous Formation of Advanced Glycation Endproducts: Emerging Mechanisms of Disease. Nutrients 9 (4). 10.3390/nu9040385 - DOI - PMC - PubMed
    1. Aron-Wisnewsky J., Clément K. (2016). The Gut Microbiome, Diet, and Links to Cardiometabolic and Chronic Disorders. Nat. Rev. Nephrol. 12 (3), 169–181. 10.1038/nrneph.2015.191 - DOI - PubMed

LinkOut - more resources